Lin’s new chapters
Lin Bioscience looks ahead to Taiwan, U.S. listings to fund clinical programs
Taiwanese biotech Lin Bioscience Inc. and its wholly owned San Diego subsidiary Lin Bioscience Co. Ltd. are planning sequential listings in Taiwan and the U.S. to fund clinical programs targeting different markets.
Lin has two preclinical
